Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
about
Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac DeathGraft rejection - endogenous or allogeneic?Dangers within: DAMP responses to damage and cell death in kidney disease.Heat shock proteins in chronic kidney disease.Hyperosmolarity impedes the cross-priming competence of dendritic cells in a TRIF-dependent manner.Transition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model.Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiologySoluble biglycan as a biomarker of inflammatory renal diseases.HMGB1 in health and disease.Role of TREM1-DAP12 in renal inflammation during obstructive nephropathy.Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation.Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation.Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft RejectionAbsence of MyD88 signaling induces donor-specific kidney allograft toleranceInnate immunity and organ transplantation: focus on lung transplantation.Biglycan: a multivalent proteoglycan providing structure and signalsThe immunomodulatory role of carbon monoxide during transplantation.Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats.Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.TLR2 and TLR4 in ischemia reperfusion injury.Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.Role of TLRs and DAMPs in allograft inflammation and transplant outcomes.Effect of dexmedetomidine on lung ischemia‑reperfusion injury.Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction.Inflammatory Mechanisms of Organ Crosstalk during Ischemic Acute Kidney Injury.Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity.The innate immune response to ischemic injury: a multiscale modeling perspective.Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat.Inhibition of innate co-receptor TREM-1 signaling reduces CD4(+) T cell activation and prolongs cardiac allograft survival.Blocking innate immunity to slow the progression of chronic kidney disease.Modulation of Innate Immune Cells to Create Transplant ToleranceRhoh deficiency reduces peripheral T-cell function and attenuates allogenic transplant rejection
P2860
Q26744359-0CDD69E4-DD77-44C9-AD4C-1268188D0A44Q26866523-E8F59888-8C90-4A42-82D2-7C4B168EB5C1Q30380000-C4395B70-B68A-4B53-AFC7-509AE867AD9EQ30397992-1B3E68E7-ED8B-43B5-A27D-BF6F11322160Q30849501-D0B62958-66E1-4419-B143-751EE6ABCC27Q33755928-73B76FE7-ACFC-44A2-A932-384BD6C8B0CBQ33819300-7088A911-3159-43D1-A3F8-8B1CE509E54FQ34160971-CB5BFB38-5936-4AB0-95BE-0BE59FD14DFEQ34622835-D02B54BB-4B98-4EE9-A711-0E38F26C1C7DQ35072795-EC8AA837-3CB3-46C9-B29B-408DD5E3178CQ36012754-6B290279-A6D6-467C-92A9-FB91C21BB43BQ36036730-DE52EB48-220F-4C5B-B23A-F6E5DC639F9CQ36131905-3F02F69C-975F-4682-BF7C-340D3D0A11FBQ36223307-30D45D59-FDD5-4B63-B930-0C9ED7861656Q36280335-682C650A-34F5-4E81-B5E6-99EDD34DCD27Q36420171-63346420-7DF2-48BA-8F94-CEDE4430072BQ36481626-12F5C52A-1F0B-473D-9494-9747CB00BD0DQ36639246-4DFFD65B-ADC4-452E-BF94-F7BA0750A7F5Q37688446-1B9F78A2-4391-424B-A350-339C5F3B824BQ37707474-263E3615-38BD-4A0D-9C5A-DFB5BBBA93F6Q37772401-BA8B009D-A2FB-4E96-93FA-D972A8103163Q38325712-ED1B5C18-3C41-4D52-95D1-69888748AF83Q38793108-43EB6FB2-CB49-4A74-88EA-B06021B316C3Q41880524-7DC77BF0-C196-4141-B854-F0EBE7A71A84Q41939161-27B9DBBC-8E53-459F-BF4D-1B8C87A20657Q42134907-4235DBBD-00EA-41A8-A38D-850683177020Q42764517-232B4EB5-67DC-4C0D-A19A-D293FD53365FQ42775234-7ED4E118-DEC3-4750-A747-A84C19E934CBQ51538354-1C14FEED-6B99-4625-9FBD-CB15AFF0C3F5Q52327759-CF737C15-F217-4B74-B533-97CE2B51007DQ53656379-3F92EB03-6E48-492B-9F4B-A02D5B048292Q54269836-ED8375CD-BB7A-4183-A81F-B9163C095E8AQ54332028-6B8CA86F-0FC3-4A87-B181-D4873BB56238Q57202180-89480B34-4A90-4840-ADB5-DE8FCAC46851Q57510549-E5CA073A-E072-4387-BC9A-5F20985E36CF
P2860
Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Recipient Toll-like receptors ...... and TRIF-dependent signaling.
@en
Recipient Toll-like receptors ...... and TRIF-dependent signaling.
@nl
type
label
Recipient Toll-like receptors ...... and TRIF-dependent signaling.
@en
Recipient Toll-like receptors ...... and TRIF-dependent signaling.
@nl
prefLabel
Recipient Toll-like receptors ...... and TRIF-dependent signaling.
@en
Recipient Toll-like receptors ...... and TRIF-dependent signaling.
@nl
P2093
P356
P1476
Recipient Toll-like receptors ...... - and TRIF-dependent signaling
@en
P2093
Carsten J Kirschning
Christoph Schmaderer
Claudia Schmidt
Hermann-Josef Gröne
Mahnaz Bonrouhi
Norbert Gretz
Shijun Wang
Zoran V Popovic
P304
P356
10.1242/DMM.003533
P577
2009-12-28T00:00:00Z